Large Cell Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Large Cell Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors [Phase 2]
Phase 2 clinical trial evaluating the IDH2 inhibitor enasidenib (Idhifa) in IDH2-mutated malignant sinonasal and skull base tumors is curren…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating cabozantinib (XL184) in combination with nivolumab and ipilimumab for poorly differentiated neuroendocrine tumors; …
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma [NA]
Clinical trial evaluating sequencing-based stratification for frontline treatment in high-grade neuroendocrine carcinoma has completed and r…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for rovalpituzumab tesirine in DL3-expressing advanced solid tumors shows termination with results posted.